Skip to main content
    A

    Alto Neuroscience, Inc. (ANRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $27.14
    -2.40 (-8.12%)

    Market Cap: $1.18B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Alto Neuroscience, Inc. (ANRO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Alto Neuroscience are Annexon (ANNX), Forte Biosciences (FBRX) and Rapport Therapeutics, Inc. Common Stock (RAPP). By market cap, Alto Neuroscience ranks 11th of the 13 companies on this page; Denali Therapeutics (DNLI) is the largest at $3.00B.

    Peer Comparison

    ANRO's ROIC of -23.5% is below the peer median of -18.7%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Alto Neuroscience (ANRO)$1.18BN/AN/A0.0%-23.5%0.0%0.00%
    Annexon Inc (ANNX)$747.79MN/AN/A0.0%-84.6%0.0%0.00%
    Forte Biosciences Inc (FBRX)$1.63BN/AN/A0.0%N/A0.0%0.00%
    Rapport Therapeutics, Inc. Common Stock (RAPP)$1.55BN/A59.3x0.0%N/A0.0%0.00%
    Nuvation Bio Inc (NUVB)$1.41BN/A6.7x-67.4%-18.7%242.6%0.00%
    Harmony Biosciences Holdings (HRMY)$1.98B9.6x1.9x18.0%13.7%12.3%0.00%
    Structure Therapeutics Inc. American Depositary Shares (GPCR)$1.43BN/AN/A0.0%N/A0.0%0.00%
    Nektar Therapeutics (NKTR)$1.27BN/A23.9x0.0%N/A-20.4%0.00%
    Inhibrx Biosciences, Inc. (INBX)$1.23BN/A610.4x0.0%-66.0%-100.0%0.00%
    Alpha Tau Medical Ltd (DRTS)$1.24BN/AN/A0.0%-176.9%0.0%0.00%
    Adlai Nortye Ltd. American Depositary Shares (ANL)$683.26MN/A8.1x-124.8%-7.3%178.1%0.00%
    Denali Therapeutics Inc (DNLI)$3.00BN/A159.3x0.0%N/A-100.0%0.00%
    Innoviva Inc (INVA)$1.35B5.3x3.0x44.1%10.8%-1.6%0.00%
    Peer median$1.38B7.4x16.0x0.0%-18.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Alto Neuroscience, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Annexon Inc (ANNX)
    Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases.
    ANNX competitors
    Forte Biosciences Inc (FBRX)
    Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
    Rapport Therapeutics, Inc. Common Stock (RAPP)
    Rapport Therapeutics, Inc. is a pioneering biotechnology company dedicated to the advancement of therapeutics for neurodegenerative diseases...
    RAPP competitors
    Nuvation Bio Inc (NUVB)
    Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology.
    NUVB competitors
    Harmony Biosciences Holdings (HRMY)
    Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders.
    HRMY competitors
    Structure Therapeutics Inc. American Depositary Shares (GPCR)
    Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic...
    GPCR competitors
    Nektar Therapeutics (NKTR)
    Nektar Therapeutics is a biopharmaceutical company.
    NKTR competitors
    Inhibrx Biosciences, Inc. (INBX)
    Inhibrx, Inc., a clinical-stage biotechnology company, is focused on developing a line of new biological therapeutic candidates.
    INBX competitors
    Alpha Tau Medical Ltd (DRTS)
    Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development...
    DRTS competitors
    Adlai Nortye Ltd. American Depositary Shares (ANL)
    Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China.
    Denali Therapeutics Inc (DNLI)
    Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States.
    DNLI competitors
    Innoviva Inc (INVA)
    Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
    INVA competitors

    Frequently Asked Questions About ANRO

    Who are Alto Neuroscience's main competitors?

    The companies most similar to Alto Neuroscience include Annexon (ANNX), Forte Biosciences (FBRX), Rapport Therapeutics, Inc. Common Stock (RAPP), Nuvation Bio (NUVB) and Harmony Biosciences Holdings (HRMY), listed from the closest match.

    Who is Alto Neuroscience's biggest competitor?

    Denali Therapeutics (DNLI) is the largest of the similar companies at $3.00B; Annexon (ANNX) is the closest match by business profile, size, sector and industry.

    How does ANRO stock compare with its competitors?

    ANRO's net margin is 0.0% against a peer median of 0.0%.

    Which of Alto Neuroscience's competitors pays a higher dividend?

    Alto Neuroscience pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Alto Neuroscience bigger than its competitors?

    No. Alto Neuroscience is 11th by market cap among the 13 companies on this page; the largest is Denali Therapeutics (DNLI) at $3.00B.